New patent for Global Blood drug OXBRYTA
Annual Drug Patent Expirations for OXBRYTA Oxbryta is a drug marketed by Global Blood Theraps and is included in two NDAs. It is available from one supplier. There are ten…
Source
Annual Drug Patent Expirations for OXBRYTA Oxbryta is a drug marketed by Global Blood Theraps and is included in two NDAs. It is available from one supplier. There are ten…
Source
Annual Drug Patent Expirations for MYRBETRIQ Myrbetriq is a drug marketed by Apgdi and is included in two NDAs. It is available from three suppliers. There are eight patents protecting…
Source
Annual Drug Patent Expirations for SUNOSI Sunosi is a drug marketed by Axsome Malta and is included in one NDA. It is available from one supplier. There are twenty-seven patents…
Source
Annual Drug Patent Expirations for MYRBETRIQ+GRANULES Myrbetriq Granules is a drug marketed by Apgdi and is included in one NDA. It is available from one supplier. There are three patents…
Source
New patent expiration for APGDI drug MYRBETRIQ GRANULES Read Post »
Annual Drug Patent Expirations for PONVORY Ponvory is a drug marketed by Janssen Pharms and is included in one NDA. It is available from one supplier. There are five patents…
Source
Annual Drug Patent Expirations for CEQUA Cequa is a drug marketed by Sun Pharm and is included in one NDA. It is available from one supplier. There are four patents…
Source
Expiring drug patents are continuously driving innovation, as branded firms seek out new high-margin opportunities. Examining the patent expirations by year can indicate which pharmaceutical companies face the most peril…
Source
Drugs facing the most patent expirations this year Read Post »
This chart shows the pharmaceutical companies with the most supplementary protection certificates (SPCs) in Norway. SPCs are used in European Union and select others to encourage pharmaceutical innovation by compensating…
Source
Which pharmaceutical companies have the most SPCs in Norway? Read Post »
Annual Drug Patent Expirations for MYCAPSSA Mycapssa is a drug marketed by Chiesi and is included in one NDA. It is available from two suppliers. There are twelve patents protecting…
Source
Annual Drug Patent Expirations for MAYZENT Mayzent is a drug marketed by Novartis and is included in one NDA. It is available from one supplier. There are two patents protecting…
Source